AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
AbbVie secures exclusive option to acquire global rights to ALV003, which has the potential to be the first therapy to treat celiac disease.
x
Opt-in to stay up-to-date on the latest news.
Every day, researchers are working to get a better understanding of celiac disease and its various presentations. Ongoing research is also exploring potential drug treatments for celiac disease. To view all information related to drug development and research, please visit our main celiac disease research page. Learn about the Beyond Celiac Science Department here.
AbbVie secures exclusive option to acquire global rights to ALV003, which has the potential to be the first therapy to treat celiac disease.
Celiac disease research could lend insight to other autoimmune diseases.
The National Foundation for Celiac Awareness (NFCA) and The Jefferson Celiac Center of Thomas Jefferson University Hospitals, Philadelphia are seeking survey participants to learn more about family testing. This survey is now closed.
A population-based probabilistic approach to risk estimation.
Founder of Gluten Free Watchdog, LLC Tricia Thompson, MS, RD, is conducting a survey to learn more about the potential implications of rice consumption by the gluten-free community.
Q&A with Donald D. Kasarda, PhD, Collaborator, Agricultural Research Service, U.S. Department of Agriculture, and NFCA Scientific/Medical Advisory Council Member explains why.
A new study explores the possibility of increased mortality rates due to persistent villous atrophy in patients diagnosed with and treated for celiac disease.
Study finds that small population may react to trace amounts of gluten; refractory celiac disease rates may be overestimated.
Researchers say the key to better gluten-free bread is in the mixing process.
NFCA launches nationwide survey to gain more insight into challenges of living gluten-free on campus.
Student researchers use DARPA funds to develop an enzyme that could break down gluten.
Study shows two molecules in wheat can trigger inflammation and immune reactions in both intestinal and non-intestinal disorders.
Research published in a leading scientific journal provides insight into how celiac disease pathology is triggered.
A new nutritional management tool for people living with celiac disease from Beth Israel Deaconess Medical Center
Study generates an enzyme that could be a potential therapeutic for celiac disease.
NFCA Scientific/Medical Advisory Council Member Alessio Fasano, M.D. and Carlo Catassi, M.D. of the Center for Celiac Research publish comprehensive review of celiac disease in the New England Journal of Medicine.
NFCA Scientific/Medical Advisory Council Member Sheila E. Crowe, MD coauthors celiac focused article.
The agency is seeking public comments on safe thresholds for the top 8 allergens. Deadline is February 7, 2013.
The Center for Celiac Research (CFCR) has announced that it will be moving to Boston, MA in January 2013.
Parents and children invited to share their experiences with gluten-free lunches and other celiac-related school elements.
Summaries of important celiac research published in October 2012.
Research suggests an increased risk of developing the condition over time in people living with both autoimmune diseases.
The pharmaceutical company shared their findings at the 2012 American College of Gastroenterology Meeting.
The study from Thomas Jefferson University wins award from American College of Gastroenterology.
World renowned researcher Dr. Alessio Fasano of the Center for Celiac Research at the University of Maryland is the recipient of the coveted Shwachman Award.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to